Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Wilson’s Disease Treatment Drugs Market Portraiture
2.1.1. Global Wilson’s Disease Treatment Drugs Market, by Indication, 2016 (Value %)
2.1.2. Global Wilson’s Disease Treatment Drugs Market, by Drug Class, 2016 (Value %)
2.1.3. Global Wilson’s Disease Treatment Drugs Market, by Geography, 2016 (Value %)
Chapter 3. Wilson’s Disease Treatment Drugs Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Top 3 Countries: Global Wilson’s Disease Drugs Market, 2015-2025 (US$ Mn)
3.7. Competitive Landscape : Global Wilson’s Disease Drugs Market, by Key Players, 2015-2025 (US$ Mn)
Chapter 4. Global Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Wilson’s Disease Drugs Market, by Indication, 2016
4.3. Hepatic
4.4. Neuropsychiatric
4.5. Ophthalmic
4.6. Others (Heart and Kidney Complications)
Chapter 5. Global Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Wilson’s Disease Drugs Market, by Drug Class, 2016
5.2. Chelators
5.2.1. Penicillamine
5.2.2. Trientine
5.3. Minerals
5.3.1. Zinc Acetate
5.4. Pipeline Analysis
5.4.1. Phase III Drug
5.4.1.1. WTX101 (bis-choline tetrathiomolybdate)
Chapter 6. Global Wilson’s Disease Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Wilson’s Disease Drugs Market Analysis, 2015 – 2025
6.2.1. North America Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
6.2.2. North America Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
6.2.3. North America Wilson’s Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Wilson’s Disease Drugs Market Analysis, 2015 – 2025
6.3.1. Europe Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
6.3.2. Europe Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
6.3.3. Europe Wilson’s Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Wilson’s Disease Drugs Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Wilson’s Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of Asia Pacific
6.5. Latin America Wilson’s Disease Drugs Market Analysis, 2015 – 2025
6.5.1. Latin America Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Wilson’s Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa Wilson’s Disease Drugs Market Analysis, 2015 – 2025
6.6.1. Middle East and Africa Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
6.6.2. Middle East and Africa Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
6.6.3. Middle East and Africa Wilson’s Disease Drugs Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of Middle East and Africa
Chapter 7. Company Profiles
7.1. Kadmon Holdings, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Merck & Co.
7.3. Noble Pharma Co., Ltd.
7.4. Teva Pharmaceutical Industries Limited
7.5. Tsumura & Co.
7.6. Valeant Pharmaceuticals International, Inc.
7.7. VHB Life Sciences, Inc.
7.8. Wilson’s Therapeutics AB
List of Figures
FIG. 1 Wilson’s Disease Drugs: Market Segmentation
FIG. 2 Global Wilson’s Disease Drugs Market Share, by Indication, 2016 (Value %)
FIG. 3 Global Wilson’s Disease Drugs Market Share, by Drug Class, 2016 (Value %)
FIG. 4 Global Wilson’s Disease Drugs Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Hepatic Indications Market for Wilson’s Disease Drugs, 2015 – 2025 (US$ Mn)
FIG. 8 Global Neuropsychiatric Indications Market for Wilson’s Disease Drugs, 2015 – 2025 (US$ Mn)
FIG. 9 Global Ophthalmic Indications for Wilson’s Disease Drugs, 2015 – 2025 (US$ Mn)
FIG. 10 Global Other Indications Market for Wilson’s Disease Drugs, 2015 – 2025 (US$ Mn)
FIG. 11 Global Penicillamine Market for Wilson’s Disease Drugs, 2015 – 2025 (US$ Mn)
FIG. 12 Global Trientine Market for Wilson’s Disease Drugs, 2015 – 2025 (US$ Mn)
FIG. 13 Global Zinc Acetate Market for Wilson’s Disease Drugs, 2015 – 2025 (US$ Mn)
FIG. 14 U.S. Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 15 Canada Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 16 U.K. Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 17 Germany Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest of Europe Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 21 India Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest of Asia Pacific Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 23 Brazil Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Latin America Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 26 GCC Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 27 Rest of Middle East and Africa Wilson’s Disease Drugs Market, 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Global Wilson’s Disease Drugs Market Portraiture
TABLE 2 Global Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 3 Global Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 4 Global Chelators Market for Wilson’s Disease Drugs, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 5 Global Minerals Market for Wilson’s Disease Drugs, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 6 Global Wilson’s Disease Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 7 North America Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 8 North America Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 9 North America Wilson’s Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Wilson’s Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Wilson’s Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Wilson’s Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Wilson’s Disease Drugs Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Wilson’s Disease Drugs Market, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Wilson’s Disease Drugs Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 22 Kadmon Holdings, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Merck & Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Noble Pharma Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Teva Pharmaceutical Industries Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Tsumura & Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Valeant Pharmaceuticals International, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 VHB Life Sciences, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Wilson Therapeutics AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)